Inteum Company
Links
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - yizhan+zhai
1
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Novel Peptidomimetics for the treatment of Doxorubicin-Induced Cardiomyopathy
Advantages: Compounds (peptidomimetic inhibitors) that prevent Doxorubicin-induced cardiomyopathy (DIC) that can occur with cancer chemotherapy Peptide therapeutics have high specificity, potency, and low toxicity when compared to traditional small molecule drugs Potentially enabling cancer patients to receive DOX treatment without compromising...
Published: 12/4/2025
|
Inventor(s):
Jianfeng Cai
,
Zhigao Wang
,
Yizhan Zhai
,
Xue Zhao
,
Xueling Ma
,
Ken Chen
Keywords(s):
Biotechnology
,
Cancer Diagnostics
,
Cancer Treatment
Category(s):
Technology Classifications > Medical > Therapeutics
,
Technology Classifications > Medical > Oncology